CLASS II Device recall · Reported 7 Mar 2018 · FDA Enforcement Report

AIRO Mobile CT System recalled by Mobius Imaging

Mobius Imaging is recalling AIRO Mobile CT System, distributed nationwide in the US. The recall was initiated on 26 Sep 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesRequested.
Quantity recalled105

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0715-2018
FDA event ID
79159
Recalling firm
Mobius Imaging, Shirley, MA
Classification
Class II
Status
Terminated
Recall initiated
26 Sep 2017
FDA classified
23 Feb 2018
Reported
7 Mar 2018
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction

Timeline

26 Sep 2017Recall initiated by company
23 Feb 2018Classified by FDA+150 days
7 Mar 2018Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

If the tilt-drive motor has an intermittent connection or broken encoder or sensor wire there is a risk of unintended or unpredictable device motion while the CT system is homing the axis at startup or preparing for a scan.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

AIRO Mobile CT System, Model Number: MobiCT-32 Product Usage: The AIRO¿ is intended to be used for X-ray computed tomography applications for anatomy that can be imaged in the 107cm aperture excluding pediatric patients and patients weighing over 400 lbs. (182 kg).

Where it was distributed

Worldwide Distribution - US Nationwide in the states of: AZ, CA, CO, FL, GA, IL, KY, LA, MA, MD, MI, MN, MO, MT, NC, NY, OH, OR, PA, RI, TN, TX, UT, VA, WA, WV and the countries of Argentina, Australia, Austria, Belgium, Canada, Egypt, France, Germany, India, Italy, Japan, Kazakhstan, Lithuania, Netherlands, Pakistan, Russia, Saudi Arabia, Spain, Switzerland, UAE, Uzebekistan

Nationwide ArizonaCaliforniaColoradoFloridaGeorgiaIllinoisKentuckyLouisianaMassachusettsMarylandMichiganMinnesotaMissouriMontanaNorth CarolinaNew YorkOhioOregonPennsylvaniaRhode Island

Questions about this recall

Is AIRO Mobile CT System recalled?

Yes. Mobius Imaging recalled AIRO Mobile CT System on 26 Sep 2017. The recall is Class II and its status is Terminated. Recall number Z-0715-2018.

Why was it recalled?

If the tilt-drive motor has an intermittent connection or broken encoder or sensor wire there is a risk of unintended or unpredictable device motion while the CT system is homing the axis at startup or preparing for a scan.

Which lots are affected?

Requested.

Where was it sold?

Worldwide Distribution - US Nationwide in the states of: AZ, CA, CO, FL, GA, IL, KY, LA, MA, MD, MI, MN, MO, MT, NC, NY, OH, OR, PA, RI, TN, TX, UT, VA, WA, WV and the countries of Argentina, Australia, Austria, Belgium, Canada, Egypt, France, Germany, India, Italy, Japan, Kazakhstan, Lithuania, Netherlands, Pakistan, Russia, Saudi Arabia, Spain, Switzerland, UAE, Uzebekistan

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Mobius Imaging

All 7

Other Imaging Equipment recalls

All 2,336